Arie Belldegrun's Net Worth

$603 Million

Who is Arie Belldegrun?

Arie Belldegrun has an estimated net worth of $603 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., Cougar Biotechnology, Inc., Paramount Acquisition Corp, Kronos Bio, Inc., Ginkgo Bioworks Holdings, Inc., UroGen Pharma Ltd., Kite Pharma, Inc., Nile Therapeutics, Inc., Hana Biosciences Inc, and Arno Therapeutics, Inc.

SEC CIK

Arie Belldegrun's CIK is 0001296549

Past Insider Trading and Trends

2013 was Arie Belldegrun's most active year for acquiring shares with 37 total transactions. Arie Belldegrun's most active month to acquire stocks was the month of September. 2009 was Arie Belldegrun's most active year for disposing of shares, totalling 13 transactions. Arie Belldegrun's most active month to dispose stocks was the month of September. 2021 saw Arie Belldegrun paying a total of $6,938,992.52 for 669,006 shares, this is the most they've acquired in one year. In 2017 Arie Belldegrun cashed out on 3,782,376 shares for a total of $597,611,792.18, their largest year based on trade value.